Imatinib mesylate and the management of chronic myeloid leukemia (CML)

E-ISSN: 1308-5263

Imatinib mesylate and the management of chronic myeloid leukemia (CML) [Turk J Hematol]

Ebru Koca, İbrahim C. Haznedaroğlu
Department Of Internal Medicine, Hematology Unit, Hacettepe University School Of Medicine, Ankara, Turkey

Keywords: Chronic myeloid leukemia (CML), Imatinib mesylate, BCR-ABL, Signal transduction inhibitor.

Corresponding Author: İbrahim C. Haznedaroğlu, Türkiye
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar